Brief: Hofseth Biocare Q4 EBITDA Loss Widens To NOK 15.0 Mln

Hofseth Biocare ASA

07/02/2020 07:51

Feb 7 (Reuters) - Hofseth Biocare ASA  HOFBC.OL :
    * REG-HOFSETH BIOCARE ASA: FOURTH QUARTER 2019 FINANCIAL
REPORT
    * Q4 OPERATING REVENUES NOK 11.1 MILLION VERSUS NOK 14.5
MILLION
YEAR AGO
    * OPERATIONAL PROFIT (EBITDA) FOR Q4 2019 WAS NEGATIVE NOK
15.0M
(NOK 13.1M)

Source text for Eikon:  ID:nGNE7GXj1N 
Further company coverage:  HOFBC.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))